X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (39374) 39374
Magazine Article (505) 505
Book Chapter (73) 73
Newspaper Article (68) 68
Book / eBook (33) 33
Web Resource (9) 9
Book Review (6) 6
Dissertation (6) 6
Conference Proceeding (5) 5
Publication (5) 5
Reference (3) 3
Journal / eJournal (1) 1
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (37064) 37064
adrenal cortex hormones - therapeutic use (31194) 31194
female (17856) 17856
male (16599) 16599
adult (12158) 12158
middle aged (10270) 10270
aged (6437) 6437
child (5967) 5967
adolescent (5527) 5527
adrenal cortex hormones - administration & dosage (5522) 5522
treatment outcome (5201) 5201
corticosteroids (4330) 4330
adrenal cortex hormones - adverse effects (3990) 3990
immunosuppressive agents - therapeutic use (3855) 3855
asthma - drug therapy (3811) 3811
animals (3687) 3687
child, preschool (3234) 3234
drug therapy, combination (2979) 2979
medicine, general & internal (2821) 2821
retrospective studies (2797) 2797
prognosis (2369) 2369
diagnosis, differential (2366) 2366
time factors (2333) 2333
asthma (2280) 2280
risk factors (2256) 2256
anti-bacterial agents - therapeutic use (2231) 2231
infant (2189) 2189
therapy (2167) 2167
immunology (2139) 2139
administration, inhalation (2077) 2077
follow-up studies (1940) 1940
respiratory system (1867) 1867
anti-inflammatory agents - therapeutic use (1838) 1838
care and treatment (1812) 1812
children (1797) 1797
pediatrics (1756) 1756
pharmacology & pharmacy (1695) 1695
pregnancy (1675) 1675
severity of illness index (1672) 1672
surgery (1631) 1631
young adult (1622) 1622
diagnosis (1569) 1569
bronchodilator agents - therapeutic use (1490) 1490
chronic disease (1466) 1466
management (1459) 1459
abridged index medicus (1449) 1449
allergy (1446) 1446
double-blind (1440) 1440
dermatology (1429) 1429
steroids (1420) 1420
infant, newborn (1417) 1417
medicine & public health (1416) 1416
aged, 80 and over (1362) 1362
neurosciences (1359) 1359
acute disease (1350) 1350
drug therapy (1339) 1339
recurrence (1326) 1326
biopsy (1324) 1324
rheumatology (1311) 1311
disease (1249) 1249
health aspects (1215) 1215
analysis (1206) 1206
prospective studies (1194) 1194
research (1189) 1189
clinical neurology (1188) 1188
inflammation (1177) 1177
anti-asthmatic agents - therapeutic use (1153) 1153
adrenal cortex hormones - pharmacology (1128) 1128
anti-inflammatory agents, non-steroidal - therapeutic use (1117) 1117
adrenal cortex hormones (1069) 1069
age factors (1058) 1058
azathioprine - therapeutic use (1051) 1051
combined modality therapy (1047) 1047
endocrinology & metabolism (1008) 1008
gastroenterology & hepatology (1008) 1008
randomized controlled trials as topic (1005) 1005
transplantation (977) 977
disease progression (975) 975
clinical trials as topic (963) 963
internal medicine (929) 929
dose-response relationship, drug (908) 908
asthma - physiopathology (907) 907
cyclophosphamide - therapeutic use (891) 891
mortality (891) 891
administration, topical (889) 889
tomography, x-ray computed (887) 887
adrenergic beta-agonists - therapeutic use (878) 878
magnetic resonance imaging (872) 872
rats (866) 866
patients (850) 850
prevalence (849) 849
prednisone - therapeutic use (845) 845
administration, oral (843) 843
pulmonary disease, chronic obstructive - drug therapy (843) 843
pituitary-adrenal axis (832) 832
efficacy (831) 831
risk (830) 830
glucocorticoids (820) 820
arthritis, rheumatoid - drug therapy (811) 811
adrenocorticotropic hormone - therapeutic use (804) 804
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (21) 21
Online Resources - Online (9) 9
Collection Dvlpm't (Acquisitions) - Vendor file (1) 1
May be requested (1) 1
Scarborough Hospital - Online (1) 1
UTL at Downsview - Pharmacy (1) 1
UofT at Mississauga - Stacks (1) 1
UofT at Scarborough - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (30949) 30949
French (2876) 2876
German (2172) 2172
Italian (790) 790
Spanish (788) 788
Russian (657) 657
Japanese (539) 539
Polish (378) 378
Dutch (198) 198
Romanian (178) 178
Chinese (160) 160
Portuguese (147) 147
Czech (77) 77
Finnish (77) 77
Hungarian (75) 75
Hebrew (73) 73
Norwegian (73) 73
Croatian (57) 57
Bulgarian (56) 56
Danish (53) 53
Swedish (51) 51
Serbian (29) 29
Turkish (22) 22
Ukrainian (21) 21
Slovak (10) 10
Korean (8) 8
Lithuanian (7) 7
Arabic (3) 3
Icelandic (3) 3
Greek (2) 2
Afrikaans (1) 1
Slovenian (1) 1
Thai (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cochrane library, ISSN 1465-1858, 2016, Volume 2016, Issue 6, p. CD003725
...), and strength at two years (two‐year data on function are very limited). Corticosteroids, now part of care recommendations for DMD, are largely in routine use, although... 
Muscle Diseases | Pregnenediones | Glucocorticoids | Adrenal Cortex Hormones | Prednisone | Randomized Controlled Trials as Topic | Walking | Neurology | Duchenne muscular dystrophy | Child health | Quality of Life | Muscular dystrophies | Muscle disease | Muscular Dystrophy, Duchenne | Medicine General & Introductory Medical Sciences | Muscle Strength | Prednisolone | Corticosteroid treatment | AMERICAN ACADEMY | CONTROLLED-TRIAL | LOW-DOSAGE | Humans | Male | Adrenal Cortex Hormones [adverse effects; therapeutic use] | MEDICINE, GENERAL & INTERNAL | Glucocorticoids [adverse effects; therapeutic use] | PREDNISONE TREATMENT | Prednisolone [therapeutic use] | Prednisone [therapeutic use] | DEFLAZACORT TREATMENT | GLYCOPROTEIN COMPLEX | DOUBLE-BLIND | Muscular Dystrophy, Duchenne [drug therapy] | MOLECULAR PATHOGENESIS | Pregnenediones [therapeutic use] | STEROID-THERAPY | LONG-TERM TREATMENT | Glucocorticoids - administration & dosage | Glucocorticoids - therapeutic use | Muscular Dystrophy, Duchenne - drug therapy | Pregnenediones - administration & dosage | Adrenal Cortex Hormones - therapeutic use | Pregnenediones - therapeutic use | Adrenal Cortex Hormones - adverse effects | Muscle Strength - drug effects | Prednisolone - therapeutic use | Glucocorticoids - adverse effects | Prednisone - therapeutic use | Adrenal Cortex Hormones - administration & dosage
Journal Article
Cochrane library, ISSN 1465-1858, 2018, Volume 2018, Issue 4, p. CD006545
Background Infantile haemangiomas (previously known as strawberry birthmarks) are soft, raised swellings of the skin that occur in 3% to 10% of infants. These... 
Vascular birthmarks e.g infantile haemangiomas | Adrenal Cortex Hormones | Methylprednisolone | Photochemotherapy | topical steroids | lasers | Bleomycin | corticosteroids | Child health | systemic steroids | Propranolol | Hemangioma, Capillary | Prednisolone | Timolol | W. BIRTH MARKS AND DEVELOPMENTAL ABNORMALITIES OF THE SKIN | vincristine | Antineoplastic Agents | Radiotherapy | interferon | Remission Induction | Skin disorders | laser therapy | Randomized Controlled Trials as Topic | intralesional steroids | Skin Neoplasms | imiquimod | Adrenergic beta‐Antagonists | Lasers, Dye | Birthmarks | Skin | Medicine General & Introductory Medical Sciences | W6 Vascular malformations e.g. port‐wine stains | surgery | Antineoplastic Agents [therapeutic use] | Humans | Prednisolone [adverse effects; therapeutic use] | Child, Preschool | Infant | RANDOMIZED CONTROLLED-TRIAL | INTRALESIONAL BLEOMYCIN | MEDICINE, GENERAL & INTERNAL | PULSED DYE-LASER | Radiotherapy [methods] | TOPICAL PROPRANOLOL | Bleomycin [therapeutic use] | INTENSITY FOCUSED ULTRASOUND | TIMOLOL MALEATE 0.5-PERCENT | UNTREATED HEMANGIOMAS | SEQUENTIAL COMBINATION | RISK-FACTORS | Lasers, Dye [therapeutic use] | Remission Induction [methods] | Skin Neoplasms [therapy] | Adrenal Cortex Hormones [adverse effects; therapeutic use] | ORAL PROPRANOLOL | Hemangioma, Capillary [therapy] | Methylprednisolone [adverse effects; therapeutic use] | Photochemotherapy [methods] | Prednisolone - adverse effects | Methylprednisolone - therapeutic use | Skin Neoplasms - therapy | Hemangioma, Capillary - therapy | Photochemotherapy - methods | Timolol - administration & dosage | Methylprednisolone - adverse effects | Antineoplastic Agents - therapeutic use | Lasers, Dye - therapeutic use | Adrenal Cortex Hormones - therapeutic use | Adrenal Cortex Hormones - adverse effects | Bleomycin - therapeutic use | Propranolol - administration & dosage | Radiotherapy - methods | Remission Induction - methods | Prednisolone - therapeutic use | Adrenergic beta-Antagonists - administration & dosage
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2007, Volume 357, Issue 25, pp. 2562 - 2575
This study examines the toxicity of immunosuppressive regimens in renal-transplant recipients. A regimen containing mycophenolate mofetil, daclizumab, low-dose... 
MULTICENTER TRIAL | MEDICINE, GENERAL & INTERNAL | CYCLOSPORINE MICROEMULSION | EFFICACY | KIDNEY-TRANSPLANTATION | IMMUNOSUPPRESSION | ALLOGRAFT RECIPIENTS | TACROLIMUS | MYCOPHENOLATE-MOFETIL | SIROLIMUS | NEPHROTOXICITY | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Male | Adrenal Cortex Hormones - therapeutic use | Enzyme Inhibitors - administration & dosage | Antibodies, Monoclonal, Humanized | Calcineurin Inhibitors | Treatment Failure | Adult | Diabetes Mellitus - etiology | Female | Drug Therapy, Combination | Mycophenolic Acid - administration & dosage | Immunosuppressive Agents - administration & dosage | Sirolimus - adverse effects | Tacrolimus - administration & dosage | Prednisone - administration & dosage | Glomerular Filtration Rate | Graft Rejection - prevention & control | Kaplan-Meier Estimate | Kidney Transplantation | Immunoglobulin G - administration & dosage | Opportunistic Infections | Sirolimus - administration & dosage | Mycophenolic Acid - analogs & derivatives | Antibodies, Monoclonal - administration & dosage | Cyclosporine - administration & dosage | Immunosuppressive Agents - adverse effects | Aged | Adrenal Cortex Hormones - administration & dosage | Transplantation | Corticosteroids | Kidneys | Research | Health aspects | Immunosuppressive agents | Medical research | Immunology | Inhibitor drugs | Transplants & implants | Toxicity | Inhibidors enzimàtics | Posologia | Ús terapèutic | Corticosteroides | Rebuig (Biologia) | Posology | Therapeutic use | Immunosupressive agents | Graft rejection | Trasplantament renal | Enzyme inhibitors | Adrenocortical hormones | Immunosupressors | Kidney transplantation | Tacrolimus: administration & dosage | Medical and Health Sciences | Graft Rejection: prevention & control | Immunoglobulin G: administration & dosage | Medicin och hälsovetenskap | Mycophenolic Acid: administration & dosage | Antibodies | Klinisk medicin | Monoclonal: administration & dosage | Prednisone: administration & dosage | Adrenal Cortex Hormones: administration & dosage | Immunosuppressive Agents: administration & dosage | Mycophenolic Acid: analogs & derivatives | Sirolimus: administration & dosage | Cyclosporine: administration & dosage | Calcineurin: antagonists & inhibitors | Diabetes Mellitus: etiology | Urologi och njurmedicin | Sirolimus: adverse effects | Adrenal Cortex Hormones: therapeutic use | Enzyme Inhibitors: administration & dosage | Immunosuppressive Agents: adverse effects | Clinical Medicine | Immunosuppressive Agents: therapeutic use | Urology and Nephrology
Journal Article
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 01/2019, Volume 2019, Issue 1, p. CD005431
Background Traumatic hyphema is the entry of blood into the anterior chamber (the space between the cornea and iris) subsequent to a blow or a projectile... 
Aspirin | Bed Rest | Bandages | Patient Positioning | Adrenal Cortex Hormones | Hyphema | Eye Injuries | Tranexamic Acid | Visual Acuity | Randomized Controlled Trials as Topic | Wounds, Nonpenetrating | Antifibrinolytic Agents | Mydriatics | Platelet Aggregation Inhibitors | Estrogens, Conjugated (USP) | Eyes & vision | Medicine General & Introductory Medical Sciences | Aminocaproic Acid | Adrenal Cortex Hormones [therapeutic use] | Aspirin [therapeutic use] | Humans | Platelet Aggregation Inhibitors [therapeutic use] | SECONDARY HEMORRHAGE | MEDICINE, GENERAL & INTERNAL | Patient Positioning [methods] | STREPTOKINASE | SICKLED ERYTHROCYTES | Hyphema [etiology; therapy] | GLAUCOMA | Estrogens, Conjugated ( USP) [therapeutic use] | TOPICAL AMINOCAPROIC ACID | RISK | Wounds, Nonpenetrating [complications] | CHILDREN | TRANEXAMIC ACID | Mydriatics [therapeutic use] | Aminocaproic Acid [therapeutic use] | OUTPATIENT MANAGEMENT | Antifibrinolytic Agents [therapeutic use] | UROKINASE | Antifibrinolytic Agents - therapeutic use | Wounds, Nonpenetrating - complications | Eye Injuries - complications | Tranexamic Acid - therapeutic use | Adrenal Cortex Hormones - therapeutic use | Mydriatics - therapeutic use | Estrogens, Conjugated (USP) - therapeutic use | Patient Positioning - methods | Aminocaproic Acid - therapeutic use | Aspirin - therapeutic use | Platelet Aggregation Inhibitors - therapeutic use | Child | Hyphema - therapy | Hyphema - etiology
Journal Article
Journal Article